Homology Medicines, Inc.
GENE THERAPY METHODS

Last updated:

Abstract:

Provided are methods for reducing the risk of occurrence and/or the severity of pathogenic diseases (e.g., diseases associate with varicella zoster virus reactivation, influenza infection, and/or S. pneumoniae infection) in a subject that is receiving a gene therapy and an accompanying immunosuppressant regimen.

Status:
Application
Type:

Utility

Filling date:

5 Nov 2021

Issue date:

26 May 2022